Skip to main content
aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
6.11
-0.10 (-1.69%)
At close: Nov 13, 2026, 4:00 PM EST
6.34
+0.24 (3.87%)
After-hours: Nov 13, 2026, 7:38 PM EST

aTyr Pharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-0.190.240.3510.39-
Revenue Growth
--19.15%-33.43%-96.60%-0.66%-
Cost of Revenue
60.2260.2254.3742.2942.8123.26
Gross Profit
-60.22-60.03-54.14-41.94-32.42-23.26
Selling, General & Admin
20.517.613.7812.9813.9810.75
Research & Development
-24.82-----
Operating Expenses
-4.3117.613.7812.9813.9810.75
Operating Income
-55.91-77.63-67.91-54.92-46.4-34.02
Other Non Operating Income (Expenses)
2.583.53.894.521.060.24
EBT Excluding Unusual Items
-53.32-74.12-64.02-50.4-45.34-33.78
Pretax Income
-53.32-74.12-64.02-50.4-45.34-33.78
Earnings From Continuing Operations
-53.32-74.12-64.02-50.4-45.34-33.78
Minority Interest in Earnings
-00.01-00.010.010.01
Net Income
-53.32-74.12-64.02-50.39-45.34-33.77
Net Income to Common
-53.32-74.12-64.02-50.39-45.34-33.77
Net Income Growth
------
Shares Outstanding (Basic)
222110
Shares Outstanding (Diluted)
222110
Shares Change
10.03%25.21%38.53%88.63%48.94%108.30%
EPS (Basic)
-21.74-31.88-34.49-37.60-63.81-70.79
EPS (Diluted)
-21.74-31.88-34.49-37.60-63.81-70.79
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
--62.06-69.18-37.44-43.53-33.27
Free Cash Flow Per Share
--26.70-37.27-27.93-61.26-69.74
Operating Margin
--40856.32%-28899.57%-15557.79%-446.79%-
Profit Margin
--39009.47%-27243.83%-14274.50%-436.53%-
Free Cash Flow Margin
--32664.74%-29440.00%-10605.10%-419.09%-
EBITDA
-55.24-76.96-67.21-54.33-46.17-33.54
D&A For EBITDA
0.670.660.710.590.230.48
EBIT
-55.91-77.63-67.91-54.92-46.4-34.02
Revenue as Reported
-0.190.240.3510.39-
SEC Filings: 10-K · 10-Q